FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE

This brand name is authorized in United States. It is also authorized in Hong Kong SAR China.

Active ingredients

The drug FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Influenza, inactivated, surface antigen UNII `03BDM2QO92` - INFLUENZA A VIRUS A/HAWAII/70/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN
	Read more about Influenza, inactivated, surface antigen
`2`	Influenza, inactivated, surface antigen UNII `8Y5GN9YN6E` - INFLUENZA A VIRUS A/MINNESOTA/41/2019 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN
	Read more about Influenza, inactivated, surface antigen
`3`	Influenza, inactivated, surface antigen UNII `L7ZT1J7AEZ` - INFLUENZA B VIRUS B/WASHINGTON/02/2019 RECOMBINANT HEMAGGLUTININ ANTIGEN
	Read more about Influenza, inactivated, surface antigen
`4`	Influenza, inactivated, surface antigen UNII `POQ8DQO9S3` - INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN
	Read more about Influenza, inactivated, surface antigen

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	67049, 67050
US	FDA, National Drug Code	49281-720

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.